Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer.
Zatloukal P, Gervais R, Vansteenkiste J, Bosquee L, Sessa C, Brain E, Dansin E, Urban T, Dohollou N, Besenval M, Quoix E. Zatloukal P, et al. Among authors: vansteenkiste j. J Thorac Oncol. 2008 Aug;3(8):894-901. doi: 10.1097/JTO.0b013e31817e6669. J Thorac Oncol. 2008. PMID: 18670308 Free article. Clinical Trial.
Surgical treatment of small cell lung cancer.
Coolen L, Van den Eeckhout A, Deneffe G, Demedts M, Vansteenkiste J. Coolen L, et al. Among authors: vansteenkiste j. Eur J Cardiothorac Surg. 1995;9(2):59-64. doi: 10.1016/s1010-7940(05)80018-1. Eur J Cardiothorac Surg. 1995. PMID: 7748573
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
Vansteenkiste J, Vandebroek J, Nackaerts K, Dooms C, Galdermans D, Bosquée L, Delobbe A, Deschepper K, Van Kerckhoven W, Vandeurzen K, Deman R, D'Odemont JP, Siemons L, Van den Brande P, Dams N; Leuven Lung Cancer Group. Vansteenkiste J, et al. Lung Cancer. 2003 May;40(2):191-9. doi: 10.1016/s0169-5002(02)00515-9. Lung Cancer. 2003. PMID: 12711121 Review.
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes.
Le Chevalier T, Scagliotti G, Natale R, Danson S, Rosell R, Stahel R, Thomas P, Rudd RM, Vansteenkiste J, Thatcher N, Manegold C, Pujol JL, van Zandwijk N, Gridelli C, van Meerbeeck JP, Crino L, Brown A, Fitzgerald P, Aristides M, Schiller JH. Le Chevalier T, et al. Among authors: vansteenkiste j. Lung Cancer. 2005 Jan;47(1):69-80. doi: 10.1016/j.lungcan.2004.10.014. Lung Cancer. 2005. PMID: 15603856
Gefitinib monotherapy in advanced nonsmall cell lung cancer: a large Western community implementation study.
van Puijenbroek R, Bosquée L, Meert AP, Schallier D, Goeminne JC, Tits G, Collard P, Nackaerts K, Canon JL, Duplaquet F, Galdermans D, Germonpré P, Azerad MA, Vandenhoven G, De Greve J, Vansteenkiste J. van Puijenbroek R, et al. Among authors: vansteenkiste j. Eur Respir J. 2007 Jan;29(1):128-33. doi: 10.1183/09031936.00050706. Epub 2006 Sep 27. Eur Respir J. 2007. PMID: 17005582 Free article.
363 results